ENANTONE LP 3.75 mg, microsphères and solution for parenteral use (s.c. or i.m.) with extended release in a pre-filled syringe syringe, 1 ml
Active ingredients: LEUPRORÉLINE
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Microsphere and solution for parenteral use or with extended releasesyringe, 1 mlintramusculaire;sous-cutanée
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- ENANTONE LP 3,75 mg, microsphères et solution pour usage parentéral (S.C. ou I.M.) à libération prolongée en seringue pré-remplie
- Pharmaceutical form
- microsphère et solution pour usage parentéral ou à libération prolongée
- Route of administration
- intramusculaire;sous-cutanée
- Presentation description
- 1 seringue préremplie à 2 compartiments de 44,10 mg de poudre et de 1 mL de solvant avec système de sécurité
- Marketing authorisation holder
- TAKEDA FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 25 Jun 2018
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63589409CIP73012211CIP133400930122112Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LEUPRORÉLINEmicrosphère | 3,75 mg · une seringue pré-remplie | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.